TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies November 6, 1987
